CISATRACURIUM BESYLATE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cisatracurium Besylate Preservative Free, and what generic alternatives are available?
Cisatracurium Besylate Preservative Free is a drug marketed by Accord Hlthcare, Eugia Pharma, Fresenius Kabi Usa, Hengrui Pharma, Sandoz Inc, and Somerset Theraps Llc. and is included in six NDAs.
The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cisatracurium Besylate Preservative Free
A generic version of CISATRACURIUM BESYLATE PRESERVATIVE FREE was approved as cisatracurium besylate by SANDOZ INC on February 3rd, 2012.
Summary for CISATRACURIUM BESYLATE PRESERVATIVE FREE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 63 |
| DailyMed Link: | CISATRACURIUM BESYLATE PRESERVATIVE FREE at DailyMed |
Pharmacology for CISATRACURIUM BESYLATE PRESERVATIVE FREE
| Drug Class | Nondepolarizing Neuromuscular Blocker |
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CISATRACURIUM BESYLATE PRESERVATIVE FREE
US Patents and Regulatory Information for CISATRACURIUM BESYLATE PRESERVATIVE FREE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 205872-001 | Jun 16, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hengrui Pharma | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 204960-002 | Sep 19, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Fresenius Kabi Usa | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 203182-001 | Feb 26, 2015 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sandoz Inc | CISATRACURIUM BESYLATE PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 200154-001 | Feb 3, 2012 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
